Calcium blockers: antiatherogenic action by influencing the prostaglandin-system.
作者信息
Weiss K, Fitscha P, Gazsó A, Gludovacz D, Sinzinger H
机构信息
Atherosclerosis Research Group, Vienna, Austria.
出版信息
Prog Clin Biol Res. 1989;301:353-7.
PMID:2529552
Abstract
摘要
相似文献
1
Calcium blockers: antiatherogenic action by influencing the prostaglandin-system.钙通道阻滞剂：通过影响前列腺素系统发挥抗动脉粥样硬化作用。
Prog Clin Biol Res. 1989;301:353-7.
2
[Calcium antagonists: anti-atherosclerotic effect by modification of the prostaglandin system].[钙拮抗剂：通过改变前列腺素系统产生抗动脉粥样硬化作用]
Wien Klin Wochenschr. 1988 Nov 4;100(21):718-20.
3
4
Isradipine: a potent calcium blocker with beneficial effects on platelet function and vascular prostacyclin production.伊拉地平：一种对血小板功能和血管前列环素生成具有有益作用的强效钙阻滞剂。
Thromb Res. 1989 May 15;54(4):311-7. doi: 10.1016/0049-3848(89)90089-3.
5
Influence of calcium antagonists on platelet function and vascular prostacyclin production.钙拮抗剂对血小板功能和血管前列环素生成的影响。
Blood Press Suppl. 1994;1:75-80.
6
7
Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.地尔硫䓬和维拉帕米对[³H]尼群地平与大鼠脑钙通道位点结合的变构调节作用。
Proc West Pharmacol Soc. 1983;26:219-24.
8
Calcium channel blocking agents.钙通道阻滞剂
Med Times. 1981 Aug;109(8):36-8.
9
Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.钙通道阻滞剂对肿瘤细胞的治疗会诱导细胞骨架改变、整合素αIIbβ3的迁移以及肿瘤细胞诱导的血小板聚集。
J Cancer Res Clin Oncol. 1992;118(6):425-34. doi: 10.1007/BF01629425.
10
Calcium-channel blocking agents.钙通道阻滞剂
Clin Pharm. 1982 Jan-Feb;1(1):17-33.
Zotero 插件